معرفی
Giang Le is a Senior Research Fellow in Medicinal Chemistry at Monash University, with extensive experience in pharmaceutical research and drug discovery. He has held key research roles at leading institutions including the Institute for Molecular Bioscience (IMB), Monash Institute of Pharmaceutical Sciences (MIPS), and biotech companies Alchemia and Avexa.
His research interests lie at the intersection of medicinal chemistry, drug discovery, and pharmaceutical sciences, with a focus on developing small molecule therapeutics for diseases such as infection, pain, oncology, and respiratory disorders. His expertise spans hit identification, lead optimization, and the development of innovative platforms like the VAST™ small molecule discovery system.
The recent publications highlight a strong trend in targeting protein-protein interactions, receptor modulation, and antibacterial strategies using structure-based and fragment-based drug design. His work integrates synthetic chemistry with biological evaluation to advance therapeutic candidates.
- Drug Discovery
- Medicinal Chemistry
- Antiviral and Antibacterial Agents
- Pain and Inflammation Pathways
- Structure-Based Drug Design
Giang Le is a co-inventor on 13 patent families and has co-authored over 40 research papers, reflecting significant contributions to translational pharmaceutical research. His work has been referenced in multiple patents and cited widely, indicating high impact.
He has served as a project manager for multiple drug discovery programs and has collaborated extensively with academic and industry partners. Notably, he was listed as an inventor on a 2019 patent filed with Takeda Pharmaceutical Company Limited, underscoring ongoing industry engagement.
His research contributes to the UN Sustainable Development Goals, particularly in advancing global health through novel therapeutics.
